S&P/ASX 200 Benchmark Index Rises 1.35% This Week to 8209.50 — Data Talk
The S&P/ASX 200 Benchmark Index is up 109.55 points or 1.35% this week to 8209.50
--Largest one-week point and percentage gain since the week ending Aug. 16, 2024
--Up for two consecutive weeks
--Up 196.12 points or 2.45% over the last two weeks
--Largest two-week point and percentage gain since the week ending Aug. 23, 2024
--Up five of the past six weeks
--Today it is up 17.58 points or 0.21%
--A new record close
--Up for seven consecutive trading days
--Up 221.63 points or 2.77% over the last seven trading days
--Largest seven-day point gain since Monday, Aug. 19, 2024
--Largest seven-day percentage gain since Monday, Aug. 26, 2024
--Longest winning streak since Thursday, Aug. 22, 2024, when the market rose for 10 straight trading days
--Up 10 of the past 12 trading days
--Up 21.21% from its 52-week low of 6772.93 hit Monday, Oct. 30, 2023
--Rose 16.14% from 52 weeks ago
--Up 11.75% from its 2024 closing low of 7346.48 hit Thursday, Jan. 18, 2024
--Month-to-date it is up 1.45%
--Year-to-date it is up 618.68 points or 8.15%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 20, 2024 06:52 ET (10:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk